Central analgesic effects of aspirin-like drugs. 1995

B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
Centre de Pharmacologie, Groupe Hospitalier Pellegrin, Bordeaux, France.

Aspirin-like drugs mainly include paracetamol, salicylates and other non-steroidal anti-inflammatory drugs, and metamizole. Their analgesic effect is classically ascribed to a peripheral site of action, within the pain-processing site. There is, however, convincing evidence that a central component contributes to the overall analgesia provided by these agents. Experimental and clinical studies referring to this challenging proposal are reviewed here. The exact site and mode of action of aspirin-like drugs within the central nervous system remains controversial. It is likely that supraspinal mechanisms play an important role. Some experiments lend support to the involvement of monoaminergic control systems. Other data indicate that these drugs act centrally through the inhibition of cyclo-oxygenase activity. The interactions between prostaglandins and various neurotransmitters suggest that both mechanisms may be linked.

UI MeSH Term Description Entries
D011448 Prostaglandin Antagonists Compounds that inhibit the action of prostaglandins. Prostaglandin Inhibitors,Antagonists, Prostaglandin,Inhibitors, Prostaglandin,Prostaglandin Antagonist,Prostaglandin Inhibitor,Antagonist, Prostaglandin,Inhibitor, Prostaglandin
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000698 Analgesia Methods of PAIN relief that may be used with or in place of ANALGESICS. Analgesias
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013116 Spinal Cord A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER. Coccygeal Cord,Conus Medullaris,Conus Terminalis,Lumbar Cord,Medulla Spinalis,Myelon,Sacral Cord,Thoracic Cord,Coccygeal Cords,Conus Medullari,Conus Terminali,Cord, Coccygeal,Cord, Lumbar,Cord, Sacral,Cord, Spinal,Cord, Thoracic,Cords, Coccygeal,Cords, Lumbar,Cords, Sacral,Cords, Spinal,Cords, Thoracic,Lumbar Cords,Medulla Spinali,Medullari, Conus,Medullaris, Conus,Myelons,Sacral Cords,Spinal Cords,Spinali, Medulla,Spinalis, Medulla,Terminali, Conus,Terminalis, Conus,Thoracic Cords

Related Publications

B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
January 1992, Drugs,
B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
January 1976, Nihon Shika Ishikai zasshi,
B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
March 1970, Lancet (London, England),
B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
December 1978, European journal of pharmacology,
B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
January 1985, International journal of tissue reactions,
B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
October 1980, British journal of clinical pharmacology,
B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
July 1989, The Journal of pharmacology and experimental therapeutics,
B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
June 1996, Acta anaesthesiologica Sinica,
B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
April 1991, Clinical pharmacology and therapeutics,
B Bannwarth, and F Demotes-Mainard, and T Schaeverbeke, and L Labat, and J Dehais
December 1973, American heart journal,
Copied contents to your clipboard!